Belinda Lennox, Oxford University, UK
Belinda Lennox is an Associate Professor in the Department of Psychiatry, University of Oxford (Oxford, United Kingdom)and Honorary Consultant Psychiatrist in the Early Intervention in Psychosis service for Oxford Health NHS Foundation Trust.
She trained in General Adult Psychiatry in Nottingham, Oxford, and Cambridge in the UK. Her doctorate was in fMRI of auditory hallucinations, and she then undertook further fMRI studies in psychosis, before moving into neuroimmunology through a collaboration with Professor Alasdair Coles in the University of Cambridge and Professor Angela Vincent in the University of Oxford. Her interests are in discovering the causes of and developing more effective treatments for people with psychosis, and in implementing those discoveries into clinical practice. She runs a clinic, jointly with neuroimmunologists, for patients with neuronal cell surface antibodies and is currently running a double blind randomised controlled trial of intravenous immunoglobulin and rituximab in patients with psychosis and antibodies (the SINAPPS2 trial, www.antibodymediatedpsychosis.org).
« Go Back